DexCare, founded in 2020, is a digital health company aiming to optimize health system capacity through data-driven solutions. The company's mission is to create seamless, personalized healthcare experiences by intelligently allocating health system resources. DexCare's platform seeks to integrate with healthcare providers' existing systems to manage patient demand, service line growth, and care delivery. The company is based in Seattle, Washington.

Register To Buy and Sell Shares

For more details on financing and valuation for DexCare, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access DexCare’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like DexCare.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

DexCare investors also invested in these private companies

Team

Management Team

Derek Streat
Co-Founder & Chief Executive Officer
Rick Pittenger
Chief Technology Officer
Julia Millard
Chief Customer Experience Officer
Jamie Gier
Chief Marketing Officer
Robin Borg
Chief People Officer
Catherine Stach
Chief Product Officer
Sean O'Connor
Co-Founder & Chief Commercial Officer

Board Members

David Kereiakes
Providence Ventures
Lynne O'Keefe
Define Ventures
Todd Cozzens Ph.D
Transformation Capital

Frequently Asked Questions About DexCare’s Stock

plusminus
Can you buy DexCare’s stock?
DexCare is not publicly traded on NYSE or NASDAQ in the U.S. To buy DexCare’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell DexCare’s stock?
Yes, you can sell stock of a private company like DexCare. Forge can help you sell your DexCare stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is DexCare’s stock price?
DexCare is a privately held company and therefore does not have a public stock price. However, you may access DexCare’s private market stock price with Forge Data.
plusminus
What is DexCare’s stock ticker symbol?
DexCare does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

DexCare Appoints Robin Borg as Chief People Officer to Cultivate World-Class Talent to Fuel Growth
DexCare, Inc., the leading patient demand and care access platform, has named Robin Borg, SPHR, as chief people officer (CPO). As CPO, Borg strengthens DexCare’s recruiting and talent development process, and will further unify teams across locations. With more than 30 years of experience in human resources, Borg plays an essential role to ensure DexCare attracts and retains top-notch talent to support the company’s continued growth.
DexCare Closes $75M in Series C Funding, Led by ICONIQ Growth, to Accelerate Market Expansion of its Care Access Platform
DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access.
DexCare Reports Banner Year: Expands Access to Care to Millions of Patients and Maintains Rapid Company Growth
DexCare, Inc., the leading patient demand and care access platform, today announced its industry impact and business growth results, commemorating its two-year anniversary following its spinout from Providence.
Updated on: Jun 14, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.